| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-M00053801 |
| PharmacoGx | BRD-M00053801 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BPTF | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | CDC42EP2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | DVL2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | ILF3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | L3HYPDH | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | AGPS | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | RP11-624J6.2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | NBPF19 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | ZNF248 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | DOCK11 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
